Patents by Inventor Magnus Andersson

Magnus Andersson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9264692
    Abstract: A depth buffer compression scheme uses bilinear patches as a predictor for depth. The scheme targets compression of scenes rendered with stochastic blur rasterization. A tile of fragments may be split into two or more regions and a higher-degree function may be fit to each region. The residuals are then stored as delta corrections.
    Type: Grant
    Filed: April 26, 2012
    Date of Patent: February 16, 2016
    Assignee: Intel Corporation
    Inventors: Magnus Andersson, Tomas G. Akenine-Moller, Jon N. Hasselgren
  • Publication number: 20160000619
    Abstract: The present disclosure relates to a wheelchair (1) comprising: a chassis (3), a seat system (5) attached to the chassis (3), which seat system (5) has a backrest (5b) having a front side (5c) and a backside (5d), and an energy absorber (9) having a proximal end (9a) attached to the seat system (5) or joining the chassis (3), a distal end (9b) having means that enable attachment of straps or belts to the distal end (9b), and an intermediate portion (9c) extending from the proximal end (9a) to the distal end (9b) in a direction from the front side (5c) towards the back side (5d), wherein the intermediate portion (9c) has a curved portion adapted to straighten and plastically deform when the energy absorber (9) is subjected to a pulling force above a predetermined threshold.
    Type: Application
    Filed: March 6, 2014
    Publication date: January 7, 2016
    Inventor: Magnus Andersson
  • Publication number: 20150377739
    Abstract: A reliability range is determined for a parameter of a component in a machine subjected to life reducing loads during operation, comprising the steps of: acquiring, for each of a plurality of load sessions, at least one parameter value for said component; generating a distribution pattern containing said parameter values for the plurality of load sessions; assigning a reliability range for the distribution pattern, wherein parameter values outside said reliability range are considered as being unrealistic; analyzing the parameter values outside the reliability range to determine which of said parameter values outside the reliability range are confirmed to be unrealistic; and adjusting the reliability range if a ratio between the confirmed unrealistic parameter values and the considered unrealistic parameter values is outside a further range being predetermined for the ratio.
    Type: Application
    Filed: September 12, 2012
    Publication date: December 31, 2015
    Inventors: Magnus Andersson, Henrik Eckervald
  • Publication number: 20150379681
    Abstract: Zmin and Zmax are determined for depth offset compression. Then a check determines whether Zmin is equal to Zmax. If so, only one of Zmin and Zmax is used for depth offset compression and no index mask may be used. The bits that are saved thereby may be used for other purposes, including improving precision.
    Type: Application
    Filed: June 30, 2014
    Publication date: December 31, 2015
    Inventors: Tomas G. Akenine-Moller, Magnus Andersson
  • Patent number: 9218678
    Abstract: Multi-view rasterization may be performed by calculating visibility over a camera line. Edge equations may be evaluated iteratively along a scanline. The edge equations may be evaluated using single instruction multiple data instruction sets.
    Type: Grant
    Filed: April 25, 2011
    Date of Patent: December 22, 2015
    Assignee: Intel Corporation
    Inventors: Tomas G. Akenine-Möller, Magnus Andersson, Bjorn Johnsson
  • Patent number: 9211289
    Abstract: Behavioral pharmacological data with the compound of formula (I), a novel and selective 5HT2A/2C receptor inverse agonist, demonstrate in vivo efficacy in models of psychosis and dyskinesias. This includes activity in reversing MK-801 induced locomotor behaviors, suggesting that this compound may be an efficacious anti-psychotic, and activity in an MPTP primate model of dyskinesias, suggesting efficacy as an anti-dyskinesia agent. These data support the hypothesis that 5HT2A/2C receptor inverse agonism may confer antipsychotic and anti-dyskinetic efficacy in humans, and indicate a use of the compound of formula (I) and related agents as novel therapeutics for Parkinson's Disease, related human neurodegenerative diseases, and psychosis.
    Type: Grant
    Filed: November 10, 2014
    Date of Patent: December 15, 2015
    Assignee: ACADIA Pharmaceuticals Inc.
    Inventors: David M. Weiner, Robert E. Davis, Mark R. Brann, Carl-Magnus A. Andersson, Allan K. Uldam
  • Patent number: 9201487
    Abstract: In accordance with some embodiments, the knowledge that a capped frame time is used can be exploited to reduce power consumption. Generally a capped frame time is a pre-allocated amount of time to apply power for rendering in graphics processing. Generally the frame time involves the application of power and some down time in which only idle power is applied pending the next frame time. By making better use of that down time, power consumption reductions can be achieved in some embodiments.
    Type: Grant
    Filed: March 5, 2013
    Date of Patent: December 1, 2015
    Assignee: Intel Corporation
    Inventors: Tomas G. Akenine-Moller, Bjorn Johnsson, Magnus Andersson, Jim K. Nilsson, Robert M. Toth, Carl J. Munkberg, Jon N. Hasselgren
  • Publication number: 20150269771
    Abstract: In accordance with some embodiments, a full per sample coverage mask may be used for a subset of the pixels in the tile, thereby enabling pixels that belong to multiple depth ranges to be handled. This makes the depth bounds a tighter fit for the true depth range of the tile and improves hierarchical depth culling efficiency when MSAA is used.
    Type: Application
    Filed: March 18, 2014
    Publication date: September 24, 2015
    Inventors: Jon N. Hasselgren, Magnus Andersson
  • Publication number: 20150259291
    Abstract: Compounds and methods are provided for the treatment of disease conditions in which modification of serotonergic receptor activity has a beneficial effect. In the method, an effective amount of a compound is adminstered to a patient in need of such treatment.
    Type: Application
    Filed: February 20, 2015
    Publication date: September 17, 2015
    Inventors: Carl-Magnus A. ANDERSSON, Glenn CROSTON, Eva Louise HANSEN, Allan Kjaersgaard ULDAM
  • Publication number: 20150234951
    Abstract: A first set of data is received relating to the operation of a first mechanical part. A plurality of steady state conditions for the first set of operational data is determined. A load history is determined for the first mechanical part based on the plurality of determined steady states and the first set of operational data. One of a plurality of predefined life consumption calculation models is selected based on a type of the first mechanical part and a position of a critical area at the first mechanical part. A level of life consumption for the critical area of the first mechanical part is determined based on the selected life consumption calculation model and the determined load history.
    Type: Application
    Filed: June 19, 2012
    Publication date: August 20, 2015
    Inventors: Magnus Andersson, Peter Svensson, Fredrik Wanman
  • Patent number: 9111392
    Abstract: Unlike a static primitive, where the depth function is planar, the depth function for a moving and defocused triangle is a rational function in time and the lens parameters. Compact depth functions can be used to design an efficient depth buffer compressor/decompressor, which significantly lowers total depth buffer bandwidth usage. In addition, this compressor/decompressor is substantially simpler in the number of operations needed to execute, which makes it more amenable for hardware implementation than previous methods.
    Type: Grant
    Filed: December 20, 2012
    Date of Patent: August 18, 2015
    Assignee: Intel Corporation
    Inventors: Magnus Andersson, Carl J. Munkberg, Tomas G. Akenine-Moller, Jon N. Hasselgren
  • Publication number: 20150227659
    Abstract: A life consumption of a component in a machine may be predicted. Load data may be received from a load session of said machine. A plurality of parameter sets may be accessed, each associated with a critical point of said component, which point is considered to have critical life consumption. For each critical point, life consumption may be calculated using a life consumption calculation model receiving said load data and said parameter sets as input. By selecting a plurality of critical points on the component, a more complete view is presented of how the different parts of the component are affected by the load session.
    Type: Application
    Filed: June 19, 2012
    Publication date: August 13, 2015
    Applicant: GKN Aerospace Sweden AB
    Inventors: Magnus Andersson, Anders Larsson
  • Publication number: 20150202194
    Abstract: Behavioral pharmacological data with the compound of formula (I), a novel and selective 5HT2A/2C receptor inverse agonist, demonstrate in vivo efficacy in models of psychosis and dyskinesias. This includes activity in reversing MK-801 induced locomotor behaviors, suggesting that this compound may be an efficacious anti-psychotic, and activity in an MPTP primate model of dyskinesias, suggesting efficacy as an anti-dyskinesia agent. These data support the hypothesis that 5HT2A/2C receptor inverse agonism may confer antipsychotic and anti-dyskinetic efficacy in humans, and indicate a use of the compound of formula (I) and related agents as novel therapeutics for Parkinson's Disease, related human neurodegenerative diseases, and psychosis.
    Type: Application
    Filed: November 10, 2014
    Publication date: July 23, 2015
    Inventors: David M. Weiner, Robert E. Davis, Mark R. Brann, Carl-Magnus A. Andersson, Allan K. Uldam
  • Publication number: 20150199623
    Abstract: A method for planning attacking targets to optimize a use of own available resources in a target area based upon information on own resources available for attacking and information on protected and non-protected targets located in the target area. Different attack tactics are collected in a first library. Different defense strategies are collected in a second library. A reward value is allotted to each target and threat in the target area. Each target and threat in the target area has a defense capability and a vulnerability. The different attack tactics for a chosen defense strategy are evaluated to find an optimal attack tactic having a highest possible accumulated value of target reward value combined with a defeat probability value. The found optimal attack tactic is utilized to create an attack plan involving information on resources needed, targets to attack and attacking directions and time delays.
    Type: Application
    Filed: May 11, 2012
    Publication date: July 16, 2015
    Applicant: SAAB AB
    Inventors: Magnus Andersson, Kristian Lundberg, Nils-Hassan Quttineh
  • Publication number: 20150187124
    Abstract: Because using the same number of bits per residual depth offset compression is not the best distribution of bits, the bits per residual may be distributed instead according to the content of the depths of a tile. For example, if the depth differences close to the Zmax are small, then fewer bits can be spent on residuals for the samples that are encoded relative to Zmax. Consequently, more bits can be spent on the residuals for the samples that are encoded relative to Zmin. As a result, more tiles succeed at compressing to the required number of bits.
    Type: Application
    Filed: December 27, 2013
    Publication date: July 2, 2015
    Inventors: Tomas G. Akenine-Moller, Magnus Andersson, Jon N. Hasselgren, Carl J. Munkberg, Robert M. Toth
  • Publication number: 20150187125
    Abstract: In accordance with some embodiments, a full per sample coverage mask may be used for a subset of the pixels in the tile, thereby enabling pixels that belong to multiple depth ranges to be handled. This makes the depth bounds a tighter fit for the true depth range of the tile and improves hierarchical depth culling efficiency when MSAA is used.
    Type: Application
    Filed: December 27, 2013
    Publication date: July 2, 2015
    Inventors: Jon N. Hasselgren, Magnus Andersson
  • Publication number: 20150161815
    Abstract: A simple technique for zmax-culling on a per-tile basis conservatively estimates the maximum depth of the samples in a tile using a layer of masks and a number of zmax-values. No feedback loop is needed from the depth unit, in some embodiments. In addition, the occlusion test may be masked.
    Type: Application
    Filed: December 9, 2013
    Publication date: June 11, 2015
    Inventors: Magnus Andersson, Tomas G. Akenine-Moller, Jon N. Hasselgren
  • Patent number: 9003041
    Abstract: A multimedia provider (100) generates, based on a request for a media channel from a user terminal (10), a session set-up description that is returned to the user terminal (10). The description defines, when processed in the terminal (10), a session window (20) that is displayed on a screen (12) of the terminal and comprises a region (22) for displaying media data of a requested channel and a channel region (24) comprising information on alternative available media channels. The description also defines a binding between user inputs (14) of the terminal (10) and identifiers of the alternative channels. The set-up description allows for a user-friendly channel switch by automatically transmitting a channel switch request to the multimedia provider (100) upon a triggering of the user input (14) that is associated with the identifier of the requested media channel. The description, thus, provides a visually appealing graphical interface and simultaneously allows for a user-friendly media channel switch.
    Type: Grant
    Filed: November 24, 2005
    Date of Patent: April 7, 2015
    Assignee: Telefonaktiebolaget LM Ericsson (publ)
    Inventors: Torbjörn Einarsson, Anders Nohlgren, Magnus Westerlund, Magnus Andersson
  • Publication number: 20150015043
    Abstract: The present disclosure relates to a wheelchair (1) with tilt capabilities. The electric wheelchair comprises a chassis (3), a lift device having a base member which is fixedly arranged to the chassis, and a lifting member arranged to move rectilinearly relative to the base member along an axis defined by a longitudinal extension of the lifting member, a tilt frame, a first arm pivotally coupled to the lifting member and the tilt frame, and a second arm coupled to the base member, and which second arm is pivotally coupled to the first arm forming a pivot connection, wherein movement of the lifting member towards the extended position moves the pivot connection towards the base member and movement of the lifting member towards the retracted position moves the pivot connection away from the base member.
    Type: Application
    Filed: July 10, 2014
    Publication date: January 15, 2015
    Inventors: Jonas Jahkel, Goran Mansson, Stefan Nilzen, Johnny Nordin, Rune Stenstrom, Hakan Bergman, Magnus Andersson, Richard Ronngardh, Ake Melander, Bo Engman, Adam Karpinski, Corey Blauch, Lori Weaver, Mehdi Mirzaie
  • Patent number: 8921393
    Abstract: Behavioral pharmacological data with the compound of formula (I), a novel and selective 5HT2A/2C receptor inverse agonist, demonstrate in vivo efficacy in models of psychosis and dyskinesias. This includes activity in reversing MK-801 induced locomotor behaviors, suggesting that this compound may be an efficacious anti-psychotic, and activity in an MPTP primate model of dyskinesias, suggesting efficacy as an anti-dyskinesia agent. These data support the hypothesis that 5HT2A/2C receptor inverse agonism may confer antipsychotic and anti-dyskinetic efficacy in humans, and indicate a use of the compound of formula (I) and related agents as novel therapeutics for Parkinson's Disease, related human neurodegenerative diseases, and psychosis.
    Type: Grant
    Filed: November 21, 2013
    Date of Patent: December 30, 2014
    Assignee: ACADIA Pharmaceuticals Inc.
    Inventors: David M. Weiner, Robert E. Davis, Mark R. Brann, Carl-Magnus A. Andersson, Allan K. Uldam